Nu Skin Enterprises (NYSE:NUS) released its earnings data on Wednesday. The company reported $1.13 EPS for the quarter, missing the Thomson Reuters consensus estimate of $1.27 by $0.14, American Banking & Market News reports. The company had revenue of $650.00 million for the quarter, compared to the consensus estimate of $709.03 million. During the same quarter in the prior year, the company posted $1.22 earnings per share. The company’s quarterly revenue was down 3.1% on a year-over-year basis. Nu Skin Enterprises updated its Q3 guidance to $0.90-0.95 EPS and its Q4 guidance to $1.00-1.05 EPS.
Shares of Nu Skin Enterprises (NYSE:NUS) traded up 2.32% on Thursday, hitting $47.60. 2,397,351 shares of the company’s stock traded hands. Nu Skin Enterprises has a one year low of $43.50 and a one year high of $140.50. The stock has a 50-day moving average of $67.82 and a 200-day moving average of $76.23. The company has a market cap of $2.806 billion and a price-to-earnings ratio of 7.65. Nu Skin Enterprises also was the target of unusually large options trading on Tuesday. Stock investors purchased 2,026 call options on the company. This represents an increase of 145% compared to the typical daily volume of 828 call options.
A number of research firms have recently commented on NUS. Analysts at Canaccord Genuity cut their price target on shares of Nu Skin Enterprises from $92.00 to $53.00 in a research note on Thursday. They now have a “hold” rating on the stock. On the ratings front, analysts at JPMorgan Chase & Co. downgraded shares of Nu Skin Enterprises from an “overweight” rating to a “neutral” rating in a research note on Thursday. They now have a $50.00 price target on the stock, down previously from $100.00. Finally, analysts at Zacks downgraded shares of Nu Skin Enterprises from a “neutral” rating to an “underperform” rating in a research note on Tuesday, July 29th. They now have a $60.20 price target on the stock. Three analysts have rated the stock with a sell rating, two have assigned a hold rating and three have assigned a buy rating to the company. The company has a consensus rating of “Hold” and a consensus target price of $81.78.
Nu Skin Enterprises, Inc is a global direct selling company with operations in 53 markets worldwide. The Company develops and distributes anti-aging personal care products and nutritional supplements under its Nu Skin and Pharmanex brands, respectively.
Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.